ASXC AMEX
Asensus Surgical, Inc.
1W: +24.2%
1M: +2.7%
3M: +40.3%
1Y: +24.8%
3Y: -83.3%
5Y: -97.3%
$0.35
Last traded 2024-08-21 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$9M
+21.0% ▲
5Y CAGR: -18.7%
Gross Profit
-$5M
-21.0% ▼
Operating Income
-$79M
-5.0% ▼
Net Income
-$78M
-3.8% ▼
EPS (Diluted)
$-0.31
+3.1% ▲
EBITDA
-$74M
-15.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $9M | $3M | $8M | $7M | $9M |
| YoY Growth | -64.6% | -62.8% | +159.3% | -13.9% | +21.0% |
| Cost of Revenue | $21M | $5M | $11M | $11M | $13M |
| Gross Profit | -$12M | -$2M | -$3M | -$4M | -$5M |
| Gross Margin | -143.0% | -62.7% | -34.8% | -53.4% | -53.4% |
| R&D Expenses | $22M | $17M | $19M | $29M | $37M |
| SG&A Expenses | $47M | $27M | $33M | $35M | $36M |
| Operating Expenses | $80M | $55M | $63M | $72M | $73M |
| Operating Income | -$155M | -$60M | -$65M | -$76M | -$79M |
| Operating Margin | -1811.9% | -1902.0% | -785.0% | -1067.9% | -926.5% |
| Interest Expense | $4M | $19K | $370K | $410K | $0 |
| Income Before Tax | -$157M | -$61M | -$62M | -$75M | -$78M |
| Tax Expense | -$3M | -$2M | $225K | $318K | $314K |
| Net Income | -$154M | -$59M | -$62M | -$76M | -$78M |
| Net Margin | -1807.5% | -1868.1% | -758.8% | -1066.2% | -914.5% |
| EPS (Diluted) | $-8.69 | $-0.85 | $-0.28 | $-0.32 | $-0.31 |
| EBITDA | -$141M | -$47M | -$48M | -$64M | -$74M |
| Shares Outstanding | 18M | 71M | 227M | 236M | 250M |